期刊文献+

血液透析患者的系统性健康指导

Systematic Health Guidance of Hemodialysis Patients
下载PDF
导出
摘要 目的探讨系统性健康指导对提高血液透析患者满意度的效果。方法随机选取该院血液透析患者160例,以2014年3—9月的患者为对照组,实施常规的健康教育,以2014年10月—2015年3月的患者为观察组,实施系统性健康指导,分别测评患者的满意度。结果观察组与对照组患者的满意度差异有统计学意义(P<0.01)。结论系统性健康指导能够让血液透析患者获得更高的满意度,使患者能够更好的自我管理能力,保证了健康教育的有效性。 Objective To investigate the effect of systematic health guidance to improve the satisfaction of hemodialysis patients. Methods 160hemodialysis patients fromaⅢ-A hospital in Jilin province were randomly divided into tow groups. The patients from March to September in 2014 were selected as the control group and the patients from Octobor 2014 to April in 2015 were selected as the observation group.The control group used conventional health education and the observa-tion group received systematic health guidance. The degree of nurse service satisfaction of two groups were compared. Re-sults The nurse servicesatisfaction survey of observation group washigher than that of control group, the difference was sta-tisticallysignificant (P〈0.01). Conclusion Systematic health guidance can improve satisfaction and strengthen the ability of hemodialysis patientsself-management,to ensure the effectiveness of health education.
作者 赵永福
出处 《中国卫生产业》 2015年第18期158-161,共4页 China Health Industry
关键词 血液透析 系统性 健康指导 Hemodialysis Systematic Health guidance
  • 相关文献

参考文献6

二级参考文献53

  • 1Fisher JW. Erythropoietin: physiologic and pharmacologic aspects. Proc Soc Exp Biol Med, 1997, 216(3): 358-369.
  • 2Cohen J, Supino-Rosin L, Barzilay E, et al. Erythropoietin and its receptor: signaling and clinical manifestations. IMAJ, 2002, 4(11): 1072-1076.
  • 3Blackwell K, Gascon P, Siqounas G, et al. rhEPO and improved treatment outcomes: potential modes of action. Oncologist, 2004, 9(suppl 5): 41-47.
  • 4Jones TD, Halon M, Smith B J, et al. The development of a modified human IFN-α2b linked to the Fc portion of human IgG1 as a novel potential therapeutic for the treatment of hepatitis C virus infection. J Interferon Cytokine Res, 2004, 24(9): 560-572.
  • 5Lo KM, Sudo Y, Chen J, et al. High level expression and secretion of Fc-X fusion proteins in mammalian cells. Protein Eng, 1998, 11(6): 495-500.
  • 6Wang HT, Du Y, Zhang R, et al. Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo: PCT, WO 2007/ 085084 A1.
  • 7Macdougall IC. An overview of the efficacy and safety of novel erythropoiesis stimulating protein(NESP). Nephrol Dial Transplant, 2001, 16(suppl 3): 14-21.
  • 8Joy MS. Darbepoetin-alfa: a novel erythropoiesis-stimulating protein. Ann Pharmacother, 2002, 36(7-8): 1183-1192.
  • 9Sytkowski A J, Sytkowski, Lunn ED, et al. An erythropoietin fusion protein comprised of identical repeating domains exhibits enhanced biological proterties. J Biol Chem, 1999, 274(35): 24773-24778.
  • 10Hinton PR, Xiong JM, Johlfs MG, et al. An engineered human IgGl antibody with longer serum half-life. J Immunol, 2006, 176(1): 346-356.

共引文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部